A critical discovery in cancer investigation is occurring with the use of nanobodies to reactivate damaged p53. This essential tumor suppressor protein is frequently inactivated in many types of tumors, causing https://orangebookmarks.com/story22007516/mini-antibodies-revive-tumor-suppressor-p53-the-promising-hope-for-malignant-management